A Study With NLY01 in Subjects With Type 2 Diabetes

NCT04159766 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: NLY01
DRUG: Placebo

Sponsor

Neuraly, Inc.